HealthTell
Company

Last deal

$26.1M

Amount

Series B

Stage

09.03.2016

Date

4

all rounds

$44.8M

Total amount

General

About Company
HealthTell is a start-up that develops tools to monitor health status with a simple and inexpensive test from a single drop of blood.

Industry

Sector :

Subsector :

founded date

01.01.2010

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's immune profiling technology provides accurate and affordable diagnostic for early disease detection, analyzing the immune system's response against diseases such as autoimmune, cancer, CNS, and infectious diseases. HealthTell's platform uses diverse chemical libraries to offer unique insights into biomolecular interactions, serving as a platform technology for the biopharmaceutical, search, and clinical communities. The company operates a high throughput centralized laboratory in San Ramon, CA to support clients in biopharmaceuticals and research collaborators.
Contacts